LivaNova PLC (NASDAQ:LIVN) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Shares of LivaNova PLC (NASDAQ:LIVN) have earned a consensus rating of “Moderate Buy” from the eight analysts that are presently covering the company, MarketBeat.com reports. Two analysts have rated the stock with a hold recommendation, five have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $61.17.

Several equities research analysts recently weighed in on the stock. Barclays reduced their price target on shares of LivaNova from $58.00 to $56.00 and set an “equal weight” rating for the company in a research report on Friday, March 7th. The Goldman Sachs Group reduced their target price on LivaNova from $64.00 to $55.00 and set a “buy” rating for the company in a report on Monday, March 3rd. Wolfe Research downgraded LivaNova from an “outperform” rating to a “peer perform” rating in a report on Wednesday, February 26th. Stifel Nicolaus reduced their price objective on LivaNova from $72.00 to $60.00 and set a “buy” rating for the company in a report on Wednesday, February 26th. Finally, StockNews.com raised LivaNova from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, March 25th.

Institutional Investors Weigh In On LivaNova

Hedge funds and other institutional investors have recently made changes to their positions in the business. Vanguard Group Inc. grew its position in LivaNova by 12.7% during the fourth quarter. Vanguard Group Inc. now owns 2,349,887 shares of the company’s stock valued at $108,823,000 after buying an additional 265,291 shares during the period. Capital Research Global Investors grew its position in shares of LivaNova by 19.1% during the 4th quarter. Capital Research Global Investors now owns 1,612,818 shares of the company’s stock valued at $74,690,000 after acquiring an additional 258,730 shares during the period. Geode Capital Management LLC increased its stake in shares of LivaNova by 0.6% in the 3rd quarter. Geode Capital Management LLC now owns 1,344,949 shares of the company’s stock worth $70,676,000 after purchasing an additional 8,331 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in shares of LivaNova by 8.9% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,310,990 shares of the company’s stock worth $60,710,000 after purchasing an additional 107,693 shares in the last quarter. Finally, Redmile Group LLC raised its holdings in LivaNova by 19.3% in the 4th quarter. Redmile Group LLC now owns 1,043,539 shares of the company’s stock worth $48,326,000 after purchasing an additional 168,500 shares during the period. Hedge funds and other institutional investors own 97.64% of the company’s stock.

LivaNova Stock Down 4.1 %

NASDAQ:LIVN opened at $35.95 on Monday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.87 and a current ratio of 3.37. The firm has a market cap of $1.95 billion, a P/E ratio of 85.60 and a beta of 0.90. LivaNova has a fifty-two week low of $35.24 and a fifty-two week high of $64.48. The firm has a 50-day simple moving average of $43.47 and a two-hundred day simple moving average of $48.08.

About LivaNova

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.